Effects of the bone marrow microenvironment on hematopoietic malignancy

Bone

Volumn 48, Issue 1, 2011, Pages 115-120

  Askmyr, Maria ^a   Quach, Julie ^a   Purton, Louise E ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone marrow microenvironment; Hematopoiesis; Hematopoietic diseases; Myeloproliferation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADIPOCYTE; BLOOD CELL; BONE MARROW; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; ENDOTHELIUM CELL; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OSTEOBLAST; REGULATORY MECHANISM; REVIEW;

ANIMALS; BONE AND BONES; BONE MARROW; BONE MARROW CELLS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; MODELS, ANIMAL; STEM CELLS;

EID: 78650310299     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.06.003     Document Type: Review

References (76)

1. Trentin J.J. Determination of bone marrow stem cell differentiation by stromal hemopoietic inductive microenvironments (HIM). Am J Pathol 1971, 65:621-628.
2. Purton LE Scadden D.T. The hematopoietic stem cell niche. The Stem Cell Research Community, StemBook 2008, http://www.stembook.org, StemBook, ed, 10.3824/stembook.1.28.1.
3. Askmyr M., Sims N.A., Martin T.J., Purton L.E. What is the true nature of the osteoblastic hematopoietic stem cell niche?. Trends Endocrinol Metab 2009, 20:303-309.
4. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3:393-403.
5. Bianco P. Bone cells, osteoprogenitors, and hematopoiesis. IBMS BoneKEy 2008, 5:269-274.
6. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
7. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., Simmons P.J. Mesenchymal stem cells. Arch Med Res 2003, 34:565-571.
8. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
9. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006, 6:107-116.
10. Nagasawa T. The chemokine CXCL12 and regulation of HSC and B lymphocyte development in the bone marrow niche. Adv Exp Med Biol 2007, 602:69-75.
11. Biermann A., Graf von Keyserlingk D. Ultrastructure of reticulum cells in the bone marrow. Acta Anat (Basel) 1978, 100:34-43.
12. Weiss L. The hematopoietic microenvironment of the bone marrow: an ultrastructural study of the stroma in rats. Anat Rec 1976, 186:161-184.
13. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.G., Ross J., Haug J., Johnson T., Feng J.Q., Harris S., Wiedemann L.M., Mishina Y., Li L. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
14. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., Scadden D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
15. Martin T.J., Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005, 11:76-81.
16. Taichman R.S., Emerson S.G. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 1998, 16:7-15.
17. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
18. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Cote D., Means T.K., Luster A.D., Scadden D.T., Lin C.P. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005, 435:969-973.
19. Winkler I.G., Levesque J.P. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006, 34:996-1009.
20. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
21. Huang H., Cantor A.B. Common features of megakaryocytes and hematopoietic stem cells: what's the connection?. J Cell Biochem 2009, 107:857-864.
22. Junt T., Schulze H., Chen Z., Massberg S., Goerge T., Krueger A., Wagner D.D., Graf T., Italiano J.E., Shivdasani R.A., von Andrian U.H. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007, 317:1767-1770.
23. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., Frenette P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
24. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
25. Afan A.M., Broome C.S., Nicholls S.E., Whetton A.D., Miyan J.A. Bone marrow innervation regulates cellular retention in the murine haemopoietic system. Br J Haematol 1997, 98:569-577.
26. Calvo W., Forteza-Vila J. On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. Am J Anat 1969, 126:355-371.
27. Calvo W., Forteza-Vila J. Schwann cells of the bone marrow. Blood 1970, 36:180-188.
28. Yamazaki K., Allen T.D. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the "neuro-reticular complex". Am J Anat 1990, 187:261-276.
29. Spiegel A., Shivtiel S., Kalinkovich A., Ludin A., Netzer N., Goichberg P., Azaria Y., Resnick I., Hardan I., Ben-Hur H., Nagler A., Rubinstein M., Lapidot T. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007, 8:1123-1131.
30. Burt-Pichat B., Lafage-Proust M.H., Duboeuf F., Laroche N., Itzstein C., Vico L., Delmas P.D., Chenu C. Dramatic decrease of innervation density in bone after ovariectomy. Endocrinology 2005, 146:503-510.
31. Togari A., Arai M. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci 2008, 106:542-546.
32. Baldock P.A., Allison S.J., Lundberg P., Lee N.J., Slack K., Lin E.J., Enriquez R.F., McDonald M.M., Zhang L., During M.J., Little D.G., Eisman J.A., Gardiner E.M., Yulyaningsih E., Lin S., Sainsbury A., Herzog H. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 2007, 282:19092-19102.
33. Lundberg P., Allison S.J., Lee N.J., Baldock P.A., Brouard N., Rost S., Enriquez R.F., Sainsbury A., Lamghari M., Simmons P., Eisman J.A., Gardiner E.M., Herzog H. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 2007, 282:19082-19091.
34. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., Noda M., Clement K., Vaisse C., Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
35. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
36. Takada I., Kouzmenko A.P., Kato S. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opin Ther Targets 2009, 13:593-603.
37. Gimble J.M., Floyd Z.E. Fat circadian biology. J Appl Physiol 2009, 107:1629-1637.
38. Edwards C.M., Zhuang J., Mundy G.R. The pathogenesis of the bone disease of multiple myeloma. Bone 2008, 42:1007-1013.
39. Mundy G.R., Raisz L.G., Cooper R.A., Schechter G.P., Salmon S.E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974, 291:1041-1046.
40. Lataillade J.J., Pierre-Louis O., Hasselbalch H.C., Uzan G., Jasmin C., Martyre M.C., Le Bousse-Kerdiles M.C. Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 2008, 112:3026-3035.
41. Van Etten R.A., Shannon K.M. Focus on myeloproliferative diseases and myelodysplastic syndromes. Cancer Cell 2004, 6:547-552.
42. Yan X.Q., Brady G., Iscove N.N. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo. Oncogene 1994, 9:163-173.
43. Passegue E., Wagner E.F., Weissman I.L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 2004, 119:431-443.
44. Araki T., Mohi M.G., Ismat F.A., Bronson R.T., Williams I.R., Kutok J.L., Yang W., Pao L.I., Gilliland D.G., Epstein J.A., Neel B.G. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med 2004, 10:849-857.
45. Le D.T., Kong N., Zhu Y., Lauchle J.O., Aiyigari A., Braun B.S., Wang E., Kogan S.C., Le Beau M.M., Parada L., Shannon K.M. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 2004, 103:4243-4250.
46. Wernig G., Mercher T., Okabe R., Levine R.L., Lee B.H., Gilliland D.G. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 2006, 107:4274-4281.
47. Przepiorka D., Giralt S., Khouri I., Champlin R., Bueso-Ramos C. Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases. Am J Hematol 1998, 57:24-28.
48. Tefferi A., Vardiman J.W. Myelodysplastic syndromes. N Engl J Med 2009, 361:1872-1885.
49. Tentler D., Gustavsson P., Elinder G., Eklof O., Gordon L., Mandel A., Dahl N. A microdeletion in 19q13.2 associated with mental retardation, skeletal malformations, and Diamond-Blackfan anaemia suggests a novel contiguous gene syndrome. J Med Genet 2000, 37:128-131.
50. Toiviainen-Salo S., Mayranpaa M.K., Durie P.R., Richards N., Grynpas M., Ellis L., Ikegawa S., Cole W.G., Rommens J., Marttinen E., Savilahti E., Makitie O. Shwachman-Diamond syndrome is associated with low-turnover osteoporosis. Bone 2007, 41:965-972.
51. Maschke S.D., Seitz W., Lawton J. Radial longitudinal deficiency. J Am Acad Orthop Surg 2007, 15:41-52.
52. Raaijmakers M.H., Mukherjee S., Guo S., Zhang S., Kobayashi T., Schoonmaker J.A., Ebert B.L., Al-Shahrour F., Hasserjian R.P., Scadden E.O., Aung Z., Matza M., Merkenschlager M., Lin C., Rommens J.M., Scadden D.T. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464:852-857.
53. Walkley C.R., Olsen G.H., Dworkin S., Fabb S.A., Swann J., McArthur G.A., Westmoreland S.V., Chambon P., Scadden D.T., Purton L.E. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 2007, 129:1097-1110.
54. Walkley C.R., Shea J.M., Sims N.A., Purton L.E., Orkin S.H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007, 129:1081-1095.
55. Flores-Figueroa E., Gutierrez-Espindola G., Montesinos J.J., Arana-Trejo R.M., Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 2002, 26:677-686.
56. Kim Y.W., Koo B.K., Jeong H.W., Yoon M.J., Song R., Shin J., Jeong D.C., Kim S.H., Kong Y.Y. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 2008, 112:4628-4638.
57. Yao L., Yokota T., Xia L., Kincade P.W., McEver R.P. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 2005, 106:4093-4101.
58. Beg A.A., Sha W.C., Bronson R.T., Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev 1995, 9:2736-2746.
59. Rupec R.A., Jundt F., Rebholz B., Eckelt B., Weindl G., Herzinger T., Flaig M.J., Moosmann S., Plewig G., Dorken B., Forster I., Huss R., Pfeffer K. Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity 2005, 22:479-491.
60. Cobb B.S., Nesterova T.B., Thompson E., Hertweck A., O'Connor E., Godwin J., Wilson C.B., Brockdorff N., Fisher A.G., Smale S.T., Merkenschlager M. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005, 201:1367-1373.
61. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
62. Speck N.A., Gilliland D.G. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002, 2:502-513.
63. Levine R.L., Gilliland D.G. Myeloproliferative disorders. Blood 2008, 112:2190-2198.
64. Peterson L.F., Zhang D.E. The 8;21 translocation in leukemogenesis. Oncogene 2004, 23:4255-4262.
65. Schwieger M., Lohler J., Friel J., Scheller M., Horak I., Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med 2002, 196:1227-1240.
66. Mulloy J.C., Cammenga J., MacKenzie K.L., Berguido F.J., Moore M.A., Nimer S.D. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 2002, 99:15-23.
67. Schneider F., Bohlander S.K., Schneider S., Papadaki C., Kakadyia P., Dufour A., Vempati S., Unterhalt M., Feuring-Buske M., Buske C., Braess J., Wandt H., Hiddemann W., Spiekermann K. AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia. Leukemia 2007, 21:2199-2201.
68. Flynn C.M., Kaufman D.S. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 2007, 109:2688-2692.
69. Sala-Torra O., Hanna C., Loken M.R., Flowers M.E., Maris M., Ladne P.A., Mason J.R., Senitzer D., Rodriguez R., Forman S.J., Deeg H.J., Radich J.P. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:511-517.
70. Hertenstein B., Hambach L., Bacigalupo A., Schmitz N., McCann S., Slavin S., Gratwohl A., Ferrant A., Elmaagacli A., Schwertfeger R., Locasciulli A., Zander A., Bornhauser M., Niederwieser D., Ruutu T. Development of leukemia in donor cells after allogeneic stem cell transplantation-a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005, 90:969-975.
71. Flores-Figueroa E., Arana-Trejo R.M., Gutierrez-Espindola G., Perez-Cabrera A., Mayani H. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005, 29:215-224.
72. Blau O., Hofmann W.K., Baldus C.D., Thiel G., Serbent V., Schumann E., Thiel E., Blau I.W. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. Exp Hematol 2007, 35:221-229.
73. Menendez P., Catalina P., Rodriguez R., Melen G.J., Bueno C., Arriero M., Garcia-Sanchez F., Lassaletta A., Garcia-Sanz R., Garcia-Castro J. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 2009, 206:3131-3141.
74. Cimino G., Rapanotti M.C., Sprovieri T., Elia L. ALL1 gene alterations in acute leukemia: biological and clinical aspects. Haematologica 1998, 83:350-357.
75. Barabe F., Kennedy J.A., Hope K.J., Dick J.E. Modeling the initiation and progression of human acute leukemia in mice. Science 2007, 316:600-604.
76. Klaus M., Stavroulaki E., Kastrinaki M.C., Fragioudaki P., Giannikou K., Psyallaki M., Pontikoglou C.G., Tsoukatou D., Mamalaki C., Papadaki H.A. Reserves, functional, immunoregulatory and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev 2009.